<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02095496</url>
  </required_header>
  <id_info>
    <org_study_id>StLuc</org_study_id>
    <nct_id>NCT02095496</nct_id>
  </id_info>
  <brief_title>Efficacy of Closed-loop Ventilation to Reduced Sleep Disorders</brief_title>
  <acronym>SleepICU</acronym>
  <official_title>Contribution to the Understanding of the Involvement of Mechanical Ventilation in ICU Patients Sleep Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep's deficiencies are very common in intensive care. Mechanical ventilation is a known&#xD;
      factor in this deterioration.The investigators hypothesize that close-loop ventilation mode&#xD;
      (Intellivent-ASV) is able to minimize sleep deterioration, adjusting ventilation to the&#xD;
      patient needs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In intensive care, conventional mechanical ventilation (pressure support) generates apneas&#xD;
      and asynchronies during sleep. Intellivent-ASV would be able to avoid apneas, providing&#xD;
      controlled cycles when respiratory rate become too low. Moreover, the constant adjustment of&#xD;
      ventilatory parameters to the patient needs would avoid asynchronies between the ventilator&#xD;
      and the patient ventilatory drive.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep fragmentation index</measure>
    <time_frame>12 hours</time_frame>
    <description>= number of awakenings and arousals per hour of sleep</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>duration of sleep episodes</measure>
    <time_frame>12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distribution of the sleep</measure>
    <time_frame>12 hours</time_frame>
    <description>distribution of the sleep during day and night</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sleep's architecture</measure>
    <time_frame>12 hours</time_frame>
    <description>proportion of the different phases of sleep (slow waves sleep stage 1, 2, 3 and 4 and Rapid Eye Movement (REM) sleep)</description>
  </other_outcome>
  <other_outcome>
    <measure>ventilation</measure>
    <time_frame>12 hours</time_frame>
    <description>number of asynchronies and apneas and ventilatory variability</description>
  </other_outcome>
  <other_outcome>
    <measure>circadian rhythm</measure>
    <time_frame>6 hours</time_frame>
    <description>Plasmatic melatonin dosage</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Acute Mechanical Ventilatory Failure</condition>
  <condition>Psychosis Associated With Intensive Care</condition>
  <arm_group>
    <arm_group_label>Intellivent-ASV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive Intellivent-ASV ventilation during 12 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive pressure support ventilation during 12 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intellivent-ASV</intervention_name>
    <description>12 hours of mechanical ventilation with intellivent-ASV</description>
    <arm_group_label>Intellivent-ASV</arm_group_label>
    <other_name>closed-loop ventilation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional ventilation</intervention_name>
    <description>12 hours of mechanical ventilation with pressure support ventilation</description>
    <arm_group_label>Conventional ventilation</arm_group_label>
    <other_name>pressure support ventilation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient under invasive mechanical ventilation since at least 6 hours and for expected&#xD;
             at least 48 hours duration, including a continuous period of 24h, from 2 p.m. to 2&#xD;
             p.m. the next day.&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Body Mass Index &lt; 40&#xD;
&#xD;
          -  informed consent signed by the family&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient requiring neuo-muscular blocking agent or deep sedation enough to abolish&#xD;
             spontaneous ventilatory effort&#xD;
&#xD;
          -  patient with encephalopathy regardless of origin&#xD;
&#xD;
          -  Patient with Glasgow coma scale score &lt; 8&#xD;
&#xD;
          -  Patient abusing of drug or alcohol&#xD;
&#xD;
          -  patient with a contraindication for placement of a nasogastric tube such that&#xD;
             sufferers of esophageal or gastric ulcer, tumors, diverticulitis or bleeding varices&#xD;
             or patients with sinusitis epistaxis or having recently been operated on the nose or&#xD;
             pharynx&#xD;
&#xD;
          -  Patient with bleeding disorders&#xD;
&#xD;
          -  Patient with unstable respiratory situation as defined by a arterial oxygen partial&#xD;
             pressure and inspired oxygen fraction ratio (PaO2/FiO2) &lt; 100 mmHg with positive end&#xD;
             expiratory pressure (PEEP) &gt; 12 cmH2O&#xD;
&#xD;
          -  Patient with unstable hemodynamic situation as defined by Systolic Blood Pressure&#xD;
             (SBP) &lt; 75 mmHg despite a therapeutic optimization&#xD;
&#xD;
          -  Inclusion in another research protocol submitted to consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>94 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie Bialais, PhD Student</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intensive Care Unit, Saint Luc university Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <study_first_submitted>March 4, 2014</study_first_submitted>
  <study_first_submitted_qc>March 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2014</study_first_posted>
  <last_update_submitted>January 29, 2016</last_update_submitted>
  <last_update_submitted_qc>January 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sleep</keyword>
  <keyword>intensive care</keyword>
  <keyword>mechanical ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

